e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Sarcoidosis, interstitial lung diseases and various clinical problems
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Primary Pulmonary Amyloidosis
P. Korkmaz (Istanbul, Turkey), M. Kiyik (Istanbul, Turkey), A. Durmaz (Istanbul, Turkey), N. Mutlu (Istanbul, Turkey), H. Tigin (Istanbul, Turkey), H. Ürer (Istanbul, Turkey), K. Karapinar (Istanbul, Turkey)
Source:
International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems
Session:
Sarcoidosis, interstitial lung diseases and various clinical problems
Session type:
Thematic Poster
Number:
4118
Disease area:
Interstitial lung diseases, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Korkmaz (Istanbul, Turkey), M. Kiyik (Istanbul, Turkey), A. Durmaz (Istanbul, Turkey), N. Mutlu (Istanbul, Turkey), H. Tigin (Istanbul, Turkey), H. Ürer (Istanbul, Turkey), K. Karapinar (Istanbul, Turkey). Primary Pulmonary Amyloidosis. 4118
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
Primary pulmonary botryomycosis
Source: Eur Respir J 2007; 30: Suppl. 51, 566s
Year: 2007
Treatment of Idiopathic Pulmonary Fibrosis
Source: Guideline 2015
Year: 2015
Management of Pulmonary Carcinoid
Source: International Congress 2017 – Clinical problems in lung diseases
Year: 2017
Is Pulmonary Rehabilitation A Savior In Idiopathic Pulmonary Fibrosis?
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020
Long-term Outcome of Pulmonary Resection for Nontuberculous Mycobacterial Pulmonary Disease
Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Year: 2017
Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017
Diagnosis and Treatment of Chronic Pulmonary Embolism
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014
Diagnosis and Treatment of Chronic Pulmonary Embolism
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018
Platelet activation indices in patients with Idiopathic Pulmonary Fibrosis
Source: International Congress 2014 – ILDs 5
Year: 2014
Predictors of Progression in Patients with Pulmonary Sarcoidosis
Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Year: 2020
Pulmonary Alveolar Microlithiasis: From Diagnosis to Transplant: An Indian Experience
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019
Postoperative Pulmonary Complications in Bronchial Asthma/Chronic Obstructive Pulmonary Disease/Non-Pulmonary Disease Patients
Source: International Congress 2018 – Functional assessment of COPD
Year: 2018
Clinical characteristics of a Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Cohort
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020
Pulmonary nocardiosis
Source: Eur Respir J 2002; 20: Suppl. 38, 353s
Year: 2002
Tele-rehabilitation program in Idiopathic Pulmonary Fibrosis
Source: International Congress 2019 – M-health/e-health I
Year: 2019
The Effects Of Respiratory Viruses on The Acute Pulmonary Exacerbations In Cystic Fibrosis Patients
Source: International Congress 2019 – Insights into paediatric bronchology
Year: 2019
Pulmonary lymphangiectasia
Source: Eur Respir Monogr 2021; 92: 197-212
Year: 2021
Clinical Features of Pulmonary Hypertension
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept